Vivos Therapeutics, Inc. VVOS

Company Overview

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a U.S.-based medical technology and healthcare services company focused on the diagnosis, treatment, and management of sleep-disordered breathing conditions, including mild-to-moderate obstructive sleep apnea (OSA) and snoring. The company operates primarily within the dental sleep medicine and airway-focused healthcare markets, offering proprietary oral appliance therapies and related clinical training programs for dentists and healthcare providers. Its core commercial offerings include the Vivos Method, a treatment protocol designed to address craniofacial and airway-related conditions using customized oral appliances and multidisciplinary care approaches.

The company generates revenue through appliance sales, clinical education and training, licensing programs, and practice support services provided to dental professionals. Vivos positions itself as an alternative or complementary approach to traditional continuous positive airway pressure (CPAP) therapy, emphasizing non-invasive and patient-centered treatment pathways. Founded in 2016 and headquartered in Littleton, Colorado, the company evolved through acquisitions and development of airway-focused treatment technologies, expanding from a provider education platform into a broader sleep-health and therapeutic solutions business.